Literature DB >> 10831317

The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation.

J F Chang1, H L Zhao, J Phillips, G Greenburg.   

Abstract

MUC1 is a mucinous glycoprotein which is normally expressed on the surface of a variety of epithelia and aberrantly overexpressed on some human tumors. In this report, we demonstrate that the epithelial mucin, MUC1, is expressed on resting human peripheral blood T cells and two leukemia T cell lines, Jurkat and Hut 78. Crosslinking of MUC1 on peripheral blood T cells by plate-bound anti-MUC1 (DF3-P) antibody inhibits cell proliferation, IL-2 and GM-CSF production, and up-regulation of the IL-2 receptor upon anti-CD3 stimulation. Induction of IL-2 production by Jurkat and HUT 78 is also suppressed and cannot be reversed by the addition of anti-CD28 mAb. These findings suggest that MUC1 can be a potent negative regulator for T cell activation at the resting stage. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10831317     DOI: 10.1006/cimm.2000.1643

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

2.  A signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast.

Authors:  Paul J Cullen; Walid Sabbagh; Ellie Graham; Molly M Irick; Erin K van Olden; Cassandra Neal; Jeffrey Delrow; Lee Bardwell; George F Sprague
Journal:  Genes Dev       Date:  2004-07-15       Impact factor: 11.361

3.  Colonic epithelial cell mediated suppression of CD4 T cell activation.

Authors:  S M Cruickshank; L D McVay; D C Baumgart; P J Felsburg; S R Carding
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

4.  Limited effects of Muc1 deficiency on mouse adenovirus type 1 respiratory infection.

Authors:  Y Nguyen; Megan C Procario; Shanna L Ashley; Wanda K O'Neal; Raymond J Pickles; Jason B Weinberg
Journal:  Virus Res       Date:  2011-07-26       Impact factor: 3.303

Review 5.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

6.  Peroxisome proliferator-activated receptor gamma activation inhibits progesterone-stimulated human MUC1 expression.

Authors:  Peng Wang; Neeraja Dharmaraj; Melissa J Brayman; Daniel D Carson
Journal:  Mol Endocrinol       Date:  2010-05-19

7.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

8.  Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands.

Authors:  Marc A Williams; Stephen Bauer; Wenju Lu; Jia Guo; Scott Walter; Timothy P Bushnell; Erik P Lillehoj; Steve N Georas
Journal:  J Innate Immun       Date:  2009-11-02       Impact factor: 7.349

Review 9.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 10.  MUC1: a multifaceted oncoprotein with a key role in cancer progression.

Authors:  Sritama Nath; Pinku Mukherjee
Journal:  Trends Mol Med       Date:  2014-03-22       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.